Personalized prostate cancer care including diagnosis review, hormonal therapy, chemotherapy, targeted treatment, and advanced disease management.
Prostate cancer commonly affects men, especially with increasing age. Some cases grow slowly, while others may spread and need active treatment.
Treatment depends on PSA level, biopsy findings, Gleason score, stage, symptoms, and overall health.
Proper staging and risk assessment are important before deciding treatment.
The most common type — starts in the milk ducts and invades surrounding tissue. Accounts for about 80% of all breast cancer cases.
Begins in the lobules (milk-producing glands). Often harder to detect on imaging; requires careful clinical evaluation.
Overexpresses the HER2 protein, making it more aggressive — but highly responsive to targeted therapies like trastuzumab (Herceptin).
Lacks ER, PR, and HER2 receptors. More aggressive and treated primarily with chemotherapy and newer immunotherapy agents.
Fuelled by estrogen or progesterone. Responds well to hormone-blocking therapies such as tamoxifen or aromatase inhibitors.
A rare, rapidly progressing form that causes redness and swelling. Requires immediate, aggressive multimodal treatment.
Recognising early symptoms leads to earlier diagnosis and better outcomes.
Helps screen and monitor prostate cancer.
Helps assess local disease.
Confirms diagnosis.
May be advised for staging.
Guides treatment decisions.
Treatment depends on type, stage, and patient health. Dr. Kumar designs individualised plans:
Outcomes depend on stage, subtype, and treatment response. Modern treatments have significantly improved survival:
Many patients do well with timely treatment.
Needs planned multimodality care.
Modern treatment can help disease control.
Consult Dr. Shikhar Kumar for prostate cancer treatment planning, PSA review, staging guidance, and advanced cancer care.
Share your details and our team will help you schedule a consultation for cancer care, treatment guidance, or report review.